BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 36747258)

  • 1. Upregulation of long intergenic non-coding RNA LINC00326 inhibits non-small cell lung carcinoma progression by blocking Wnt/β-catenin pathway through modulating the miR-657/dickkopf WNT signaling pathway inhibitor 2 axis.
    Zhang Y; Yuan J; Guo M; Xiang R; Xie T; Zhuang X; Dai W; Li Q; Lai Q
    Biol Direct; 2023 Feb; 18(1):3. PubMed ID: 36747258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNA PVT1 contributes to cell growth and metastasis in non-small-cell lung cancer by regulating miR-361-3p/SOX9 axis and activating Wnt/β-catenin signaling pathway.
    Qi G; Li L
    Biomed Pharmacother; 2020 Jun; 126():110100. PubMed ID: 32197208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of NEAT1 Suppresses Cell Proliferation, Migration, and Invasion in NSCLC Via Sponging miR-153-3p.
    Zhao L; Bi M; Zhang H; Shi M
    Cancer Biother Radiopharm; 2020 Jun; 35(5):362-370. PubMed ID: 32380843
    [No Abstract]   [Full Text] [Related]  

  • 4. Circ_0067934 promotes non-small cell lung cancer development by regulating miR-1182/KLF8 axis and activating Wnt/β-catenin pathway.
    Zhao M; Ma W; Ma C
    Biomed Pharmacother; 2020 Sep; 129():110461. PubMed ID: 32768951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ginsenoside Rh2 attenuates the progression of non-small cell lung cancer by sponging miR-28-5p/STK4 axis and inactivating Wnt/β-catenin signaling.
    Ma J; Zhao D; Yu D; Song W; Yang X; Yin H
    Cancer Med; 2023 Jun; 12(11):12653-12667. PubMed ID: 37081781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulated lncRNA SNHG1 contributes to progression of non-small cell lung cancer through inhibition of miR-101-3p and activation of Wnt/β-catenin signaling pathway.
    Cui Y; Zhang F; Zhu C; Geng L; Tian T; Liu H
    Oncotarget; 2017 Mar; 8(11):17785-17794. PubMed ID: 28147312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA PKMYT1AR promotes cancer stem cell maintenance in non-small cell lung cancer via activating Wnt signaling pathway.
    He Y; Jiang X; Duan L; Xiong Q; Yuan Y; Liu P; Jiang L; Shen Q; Zhao S; Yang C; Chen Y
    Mol Cancer; 2021 Dec; 20(1):156. PubMed ID: 34856993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long Noncoding RNA DANCR Activates Wnt/β-Catenin Signaling through MiR-216a Inhibition in Non-Small Cell Lung Cancer.
    Yu JE; Ju JA; Musacchio N; Mathias TJ; Vitolo MI
    Biomolecules; 2020 Dec; 10(12):. PubMed ID: 33302540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA PRNCR1 modulates non-small cell lung cancer cell proliferation, apoptosis, migration, invasion, and EMT through PRNCR1/miR-126-5p/MTDH axis.
    Guo R; Hu T; Liu Y; He Y; Cao Y
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 31912882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long noncoding RNASEH1-AS1 exacerbates the progression of non-small cell lung cancer by acting as a ceRNA to regulate microRNA-516a-5p/FOXK1 and thereby activating the Wnt/β-catenin signaling pathway.
    Zhang C; Huang J; Lou K; Ouyang H
    Cancer Med; 2022 Apr; 11(7):1589-1604. PubMed ID: 35166053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA CCAT1 is a prognostic biomarker for the progression of oral squamous cell carcinoma via miR-181a-mediated Wnt/β-catenin signaling pathway.
    Li GH; Ma ZH; Wang X
    Cell Cycle; 2019 Nov; 18(21):2902-2913. PubMed ID: 31599709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CircRNA has_circ_0017109 promotes lung tumor progression via activation of Wnt/β-catenin signaling due to modulating miR-671-5p/FZD4 axis.
    Yang B; Zhang B; Qi Q; Wang C
    BMC Pulm Med; 2022 Nov; 22(1):443. PubMed ID: 36434577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miRNA-125b regulates apoptosis of human non-small cell lung cancer via the PI3K/Akt/GSK3β signaling pathway.
    Wang Y; Zhao M; Liu J; Sun Z; Ni J; Liu H
    Oncol Rep; 2017 Sep; 38(3):1715-1723. PubMed ID: 28713974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-142-3p/MALAT1 inhibits lung cancer progression through repressing β-catenin expression.
    Liu J; Tian W; Zhang W; Jia Y; Yang X; Wang Y; Zhang J
    Biomed Pharmacother; 2019 Jun; 114():108847. PubMed ID: 30970294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MYPT1, regulated by miR-19b-3p inhibits the progression of non-small cell lung cancer via inhibiting the activation of wnt/β-catenin signaling.
    Wang Y; Wang L; Guo J; Zuo S; Wang Z; Hua S
    Life Sci; 2021 Aug; 278():119573. PubMed ID: 33964297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SOX30, a target gene of miR-653-5p, represses the proliferation and invasion of prostate cancer cells through inhibition of Wnt/β-catenin signaling.
    Fu Q; Sun Z; Yang F; Mao T; Gao Y; Wang H
    Cell Mol Biol Lett; 2019; 24():71. PubMed ID: 31889959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-489-3p promotes malignant progression of non-small cell lung cancer through the inactivation of Wnt/β-catenin signaling pathway via regulating USP48.
    Zhang P; Li L; Wang B; Ran X; Yang S; Luo Y; Li Y; Wang Z; Liu Y; Zhu B
    Respir Res; 2022 Apr; 23(1):93. PubMed ID: 35413838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-495 inhibits the progression of non-small-cell lung cancer by targeting TCF4 and inactivating Wnt/β-catenin pathway.
    Zheng HE; Wang G; Song J; Liu Y; Li YM; Du WP
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7750-7759. PubMed ID: 30536319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long noncoding RNA SNHG16 contributes to the development of bladder cancer via regulating miR-98/STAT3/Wnt/β-catenin pathway axis.
    Feng F; Chen A; Huang J; Xia Q; Chen Y; Jin X
    J Cell Biochem; 2018 Nov; 119(11):9408-9418. PubMed ID: 30132983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loading MicroRNA-376c in Extracellular Vesicles Inhibits Properties of Non-Small Cell Lung Cancer Cells by Targeting YTHDF1.
    Zhou J; Xiao D; Qiu T; Li J; Liu Z
    Technol Cancer Res Treat; 2020; 19():1533033820977525. PubMed ID: 33280517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.